Stocksigma LogoStocksigma Logo

Meghmani Organics Delivers Robust Q2 FY27 Consolidated Earnings Growth

Meghmani Organics reported consolidated Q2 FY27 revenue from operations of ₹666.9 crore, up 16% YoY, while EBITDA rose 40% YoY to ₹73.1 crore with margins

Meghmani Organics Delivers Robust Q2 FY27 Consolidated Earnings Growth

Meghmani Organics Ltd · Investor Presentation · 04 Nov 2026, 7:37 pm

Meghmani Organics Delivers Robust Q2 FY27 Consolidated Earnings Growth Meghmani Organics reported consolidated Q2 FY27 revenue from operations of ₹666.9 crore, up 16% YoY, while EBITDA rose 40% YoY to ₹73.1 crore with margins expanding 200 bps to 11.0%. PAT surged 193% YoY to ₹33.9 crore. On a standalone basis, revenue grew 18% YoY to ₹658.2 crore, led by Crop Protection (₹496.7 crore, up 12.2% YoY) and Pigments (₹161.5 crore, up 40.4% YoY). NCLT approved the amalgamation of Kilburn Chemicals and Meghmani Crop Nutrition on 8th Oct'26, while India reimposed five-year ADD on Chinese TiO2 on 24th Oct'26.

Original exchange filing (PDF)

More announcements from Meghmani Organics Ltd

All Meghmani Organics Ltd announcements